Publiserte artikler
Oversikt over vitenskaplege artikler som er publisert frå forskningsgruppa.
- Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy / chronic fatigue syndrome
- B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment
- Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study
- Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series
- Antibodies to ß adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome
- Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
- Rituximab serum concentrations and anti-rituximab antibodies during B-cell depletion therapy for ME/CFS
- B-lymphocyte Depletion in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. A Randomized, Double-Blind, Placebo-Controlled Trial
- Studie viser ikke effekt av behandling med rituximab hos pasienter med ME/CFS
- Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study
- Reduced endothelial function in ME/CFS – results from cyclophosphamide study
Sist oppdatert 04.04.2025